Suparna Chatterjee

742 total citations
24 papers, 533 citations indexed

About

Suparna Chatterjee is a scholar working on Rheumatology, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Suparna Chatterjee has authored 24 papers receiving a total of 533 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Rheumatology, 5 papers in Endocrinology, Diabetes and Metabolism and 4 papers in Surgery. Recurrent topics in Suparna Chatterjee's work include Chronic Lymphocytic Leukemia Research (2 papers), Renal Diseases and Glomerulopathies (2 papers) and Hepatitis Viruses Studies and Epidemiology (2 papers). Suparna Chatterjee is often cited by papers focused on Chronic Lymphocytic Leukemia Research (2 papers), Renal Diseases and Glomerulopathies (2 papers) and Hepatitis Viruses Studies and Epidemiology (2 papers). Suparna Chatterjee collaborates with scholars based in India, United States and Iraq. Suparna Chatterjee's co-authors include Dipankar Sircar, Soumya Chatterjee, Rajesh Waikhom, Rajendra Pandey, Vishal Golay, Arpita Raychaudhury, Alakendu Ghosh, Nandadulal Bairagi, Jyoti Chattopadhyay and Antony Gomes and has published in prestigious journals such as SHILAP Revista de lepidopterología, Human Reproduction and American Journal of Kidney Diseases.

In The Last Decade

Suparna Chatterjee

22 papers receiving 502 citations

Peers

Suparna Chatterjee
Lawrence J. Leventhal United States
Ali Akbaş Türkiye
Miao Lin China
Atilla Topçu Türkiye
Eli̇f Oğuz Türkiye
Bing Yan China
Lawrence J. Leventhal United States
Suparna Chatterjee
Citations per year, relative to Suparna Chatterjee Suparna Chatterjee (= 1×) peers Lawrence J. Leventhal

Countries citing papers authored by Suparna Chatterjee

Since Specialization
Citations

This map shows the geographic impact of Suparna Chatterjee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suparna Chatterjee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suparna Chatterjee more than expected).

Fields of papers citing papers by Suparna Chatterjee

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Suparna Chatterjee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suparna Chatterjee. The network helps show where Suparna Chatterjee may publish in the future.

Co-authorship network of co-authors of Suparna Chatterjee

This figure shows the co-authorship network connecting the top 25 collaborators of Suparna Chatterjee. A scholar is included among the top collaborators of Suparna Chatterjee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Suparna Chatterjee. Suparna Chatterjee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Singh, Lokendra, Suparna Chatterjee, & Sanjeeb Kumar Kar. (2025). A comprehensive review of peptic ulcer disease: epidemiology, experimental models, and mechanistic insights. SHILAP Revista de lepidopterología. 13(2). 39–54.
3.
Banerjee, Sushmita, et al.. (2024). Daily compared with alternate-day levamisole in pediatric nephrotic syndrome: an open-label randomized controlled study. Pediatric Nephrology. 39(10). 2969–2977. 2 indexed citations
4.
De, Soumita, et al.. (2021). Evaluation of levels of oxidative stress as a potential biomarker in patients with rheumatoid arthritis. SHILAP Revista de lepidopterología. 10(5). 1981–1986. 4 indexed citations
5.
Chatterjee, Suparna, et al.. (2016). Clinical effectiveness and safety of low cost versus innovator brand amlodipine in hypertension: A single-blinded, randomized, crossover, noninferiority trial. Indian Journal of Pharmacology. 48(6). 706–706. 2 indexed citations
6.
Chatterjee, Suparna, et al.. (2016). Hepatic and hematological adverse effects of long-term low-dose methotrexate therapy in rheumatoid arthritis: An observational study. Indian Journal of Pharmacology. 48(5). 591–591. 14 indexed citations
7.
Chatterjee, Suparna, et al.. (2015). Cross-Sectional Study for Prevalence of Non-Steroidal Anti-Inflammatory Drug-Induced Gastrointestinal, Cardiac and Renal Complications in India: Interim Report. Gastroenterology Research. 8(3-4). 216–221. 18 indexed citations
8.
Mitra, Monjori, Nitin Shah, MMA Faridi, et al.. (2015). Long term follow-up study to evaluate immunogenicity and safety of a single dose of live attenuated hepatitis a vaccine in children. Human Vaccines & Immunotherapeutics. 11(5). 1147–1152. 9 indexed citations
9.
Chatterjee, Suparna, et al.. (2015). Myopathy induced by statin‑ezetimibe combination: Evaluation of potential risk factors. Indian Journal of Pharmacology. 47(5). 563–563. 5 indexed citations
10.
Chatterjee, Suparna, et al.. (2015). Acute and sub-chronic oral toxicity study of black tea in rodents. Indian Journal of Pharmacology. 47(2). 167–167. 10 indexed citations
11.
Sircar, Dipankar, Soumya Chatterjee, Rajesh Waikhom, et al.. (2015). Efficacy of Febuxostat for Slowing the GFR Decline in Patients With CKD and Asymptomatic Hyperuricemia: A 6-Month, Double-Blind, Randomized, Placebo-Controlled Trial. American Journal of Kidney Diseases. 66(6). 945–950. 220 indexed citations
12.
Chatterjee, Suparna, et al.. (2015). Ethnopharmacological and Phytochemical Review on Thunbergia Retz. (Montin.) Species. Medicinal & Aromatic Plants. 4(5). 13 indexed citations
13.
Chatterjee, Suparna, et al.. (2014). Clinical effectiveness and safety of escitalopram and desvenlafaxine in patients of depression with anxiety: A randomized, open-label controlled trial. Indian Journal of Pharmacology. 46(4). 433–433. 16 indexed citations
14.
Pal, Jyotirmoy, et al.. (2013). Assessment of insulin resistance in non-diabetic hypertensives in Eastern India.. PubMed. 111(3). 170, 172–3. 2 indexed citations
15.
Chatterjee, Suparna, et al.. (2011). Clinical effectiveness and safety of gemifloxacin versus cefpodoxime in acute exacerbation of chronic bronchitis: A randomized, controlled trial. Indian Journal of Pharmacology. 43(1). 40–40. 4 indexed citations
16.
Chatterjee, Suparna, et al.. (2010). Drug safety monitoring in patients of movement disorders of a tertiary care hospital. Indian Journal of Pharmacology. 42(4). 249–249. 5 indexed citations
17.
Chatterjee, Suparna, et al.. (2009). Efficacy and safety of diacerein in early knee osteoarthritis: a randomized placebo-controlled trial. Clinical Rheumatology. 28(10). 1193–1198. 32 indexed citations
18.
Gomes, Antony, et al.. (2009). The role of antioxidant properties of Nardostachys jatamansi in alleviation of the symptoms of the chronic fatigue syndrome. Behavioural Brain Research. 202(2). 285–290. 56 indexed citations
19.
Chatterjee, Suparna, Singh Rajender, Sandeep Kadam, et al.. (2009). Longer CAG repeat length in the androgen receptor gene is associated with premature ovarian failure. Human Reproduction. 24(12). 3230–3235. 21 indexed citations
20.
Bairagi, Nandadulal, Suparna Chatterjee, & Jyoti Chattopadhyay. (2008). Variability in the secretion of corticotropin-releasing hormone, adrenocorticotropic hormone and cortisol and understandability of the hypothalamic-pituitary-adrenal axis dynamics--a mathematical study based on clinical evidence. Mathematical Medicine and Biology A Journal of the IMA. 25(1). 37–63. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026